CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 141 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2016. The put-call ratio across all filers is 1.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $1,197,000 | -22.7% | 236,919 | -66.1% | 0.67% | -14.8% |
Q3 2018 | $1,549,000 | +131.5% | 698,674 | -47.4% | 0.79% | +130.0% |
Q2 2018 | $669,000 | -80.0% | 1,328,207 | -7.6% | 0.34% | -78.5% |
Q1 2018 | $3,348,000 | -7.8% | 1,436,957 | +12.4% | 1.60% | -3.3% |
Q4 2017 | $3,630,000 | +9.5% | 1,278,057 | +10.3% | 1.65% | +4.4% |
Q3 2017 | $3,314,000 | +18.1% | 1,158,719 | +2.0% | 1.58% | +22.4% |
Q2 2017 | $2,805,000 | -26.9% | 1,135,748 | +6.8% | 1.29% | -29.1% |
Q1 2017 | $3,838,000 | +22.3% | 1,063,248 | +20.0% | 1.82% | +14.3% |
Q4 2016 | $3,138,000 | -4.5% | 886,398 | +9.0% | 1.60% | -3.9% |
Q3 2016 | $3,286,000 | -8.5% | 813,273 | -0.6% | 1.66% | -10.7% |
Q2 2016 | $3,593,000 | +11.1% | 818,473 | -4.4% | 1.86% | +4.6% |
Q1 2016 | $3,235,000 | -75.2% | 855,923 | +2.9% | 1.78% | -74.5% |
Q4 2015 | $13,040,000 | +50.0% | 831,648 | +0.8% | 6.96% | +42.8% |
Q3 2015 | $8,692,000 | -57.6% | 824,681 | +1.5% | 4.88% | -48.8% |
Q2 2015 | $20,496,000 | -10.6% | 812,681 | -1.2% | 9.53% | -9.2% |
Q1 2015 | $22,927,000 | +48.7% | 822,656 | -2.6% | 10.50% | +47.6% |
Q4 2014 | $15,421,000 | +41.8% | 844,981 | +0.7% | 7.11% | +42.7% |
Q3 2014 | $10,876,000 | -17.9% | 839,167 | +3.4% | 4.98% | -13.2% |
Q2 2014 | $13,240,000 | -7.6% | 811,267 | -0.0% | 5.74% | -11.6% |
Q1 2014 | $14,336,000 | -29.2% | 811,342 | -3.0% | 6.50% | -26.2% |
Q4 2013 | $20,248,000 | -34.8% | 836,342 | -4.5% | 8.80% | -37.0% |
Q3 2013 | $31,037,000 | +82.2% | 876,020 | -19.7% | 13.97% | +63.2% |
Q2 2013 | $17,030,000 | – | 1,090,975 | – | 8.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Byrne Asset Management LLC | 86 | $2,000 | 0.00% |